img

Global Plant-Derived Recombinant Human Serum Albumin Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Plant-Derived Recombinant Human Serum Albumin Market Research Report 2024

Plant-Derived Recombinant Human Serum Albumin is a highly purified animal-, virus-, and prion-free product developed as an alternative to human serum albumin (HSA).
According to Mr Accuracy reports’s new survey, global Plant-Derived Recombinant Human Serum Albumin market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Plant-Derived Recombinant Human Serum Albumin market research.
Key manufacturers engaged in the Plant-Derived Recombinant Human Serum Albumin industry include Albumedix, Merck, Ventria (InVitria), Novozymes Biopharma, CSL Limited, LGC Group, Bipha Ayurveda (IHI Corporation), Wuhan Healthgen Biotechnology Corp. and Takeda Pharmaceutical Company Limited, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Plant-Derived Recombinant Human Serum Albumin were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Plant-Derived Recombinant Human Serum Albumin market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Plant-Derived Recombinant Human Serum Albumin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Albumedix
Merck
Ventria (InVitria)
Novozymes Biopharma
CSL Limited
LGC Group
Bipha Ayurveda (IHI Corporation)
Wuhan Healthgen Biotechnology Corp.
Takeda Pharmaceutical Company Limited
NCPC
Oryzogen
HiMedia
Grifols
Aspira Chemical
Segment by Type
OsrHSA
ScrHSA

Segment by Application


Scientific Research
Pharmaceutical
Others

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Plant-Derived Recombinant Human Serum Albumin report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Plant-Derived Recombinant Human Serum Albumin Market Overview
1.1 Product Overview and Scope of Plant-Derived Recombinant Human Serum Albumin
1.2 Plant-Derived Recombinant Human Serum Albumin Segment by Type
1.2.1 Global Plant-Derived Recombinant Human Serum Albumin Market Value Comparison by Type (2024-2034)
1.2.2 OsrHSA
1.2.3 ScrHSA
1.3 Plant-Derived Recombinant Human Serum Albumin Segment by Application
1.3.1 Global Plant-Derived Recombinant Human Serum Albumin Market Value by Application: (2024-2034)
1.3.2 Scientific Research
1.3.3 Pharmaceutical
1.3.4 Others
1.4 Global Plant-Derived Recombinant Human Serum Albumin Market Size Estimates and Forecasts
1.4.1 Global Plant-Derived Recombinant Human Serum Albumin Revenue 2024-2034
1.4.2 Global Plant-Derived Recombinant Human Serum Albumin Sales 2024-2034
1.4.3 Global Plant-Derived Recombinant Human Serum Albumin Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Plant-Derived Recombinant Human Serum Albumin Market Competition by Manufacturers
2.1 Global Plant-Derived Recombinant Human Serum Albumin Sales Market Share by Manufacturers (2024-2024)
2.2 Global Plant-Derived Recombinant Human Serum Albumin Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Plant-Derived Recombinant Human Serum Albumin Average Price by Manufacturers (2024-2024)
2.4 Global Plant-Derived Recombinant Human Serum Albumin Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Plant-Derived Recombinant Human Serum Albumin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Plant-Derived Recombinant Human Serum Albumin, Product Type & Application
2.7 Plant-Derived Recombinant Human Serum Albumin Market Competitive Situation and Trends
2.7.1 Plant-Derived Recombinant Human Serum Albumin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Plant-Derived Recombinant Human Serum Albumin Players Market Share by Revenue
2.7.3 Global Plant-Derived Recombinant Human Serum Albumin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Plant-Derived Recombinant Human Serum Albumin Retrospective Market Scenario by Region
3.1 Global Plant-Derived Recombinant Human Serum Albumin Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Plant-Derived Recombinant Human Serum Albumin Global Plant-Derived Recombinant Human Serum Albumin Sales by Region: 2024-2034
3.2.1 Global Plant-Derived Recombinant Human Serum Albumin Sales by Region: 2024-2024
3.2.2 Global Plant-Derived Recombinant Human Serum Albumin Sales by Region: 2024-2034
3.3 Global Plant-Derived Recombinant Human Serum Albumin Global Plant-Derived Recombinant Human Serum Albumin Revenue by Region: 2024-2034
3.3.1 Global Plant-Derived Recombinant Human Serum Albumin Revenue by Region: 2024-2024
3.3.2 Global Plant-Derived Recombinant Human Serum Albumin Revenue by Region: 2024-2034
3.4 North America Plant-Derived Recombinant Human Serum Albumin Market Facts & Figures by Country
3.4.1 North America Plant-Derived Recombinant Human Serum Albumin Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Plant-Derived Recombinant Human Serum Albumin Sales by Country (2024-2034)
3.4.3 North America Plant-Derived Recombinant Human Serum Albumin Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Plant-Derived Recombinant Human Serum Albumin Market Facts & Figures by Country
3.5.1 Europe Plant-Derived Recombinant Human Serum Albumin Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Plant-Derived Recombinant Human Serum Albumin Sales by Country (2024-2034)
3.5.3 Europe Plant-Derived Recombinant Human Serum Albumin Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Plant-Derived Recombinant Human Serum Albumin Market Facts & Figures by Country
3.6.1 Asia Pacific Plant-Derived Recombinant Human Serum Albumin Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Plant-Derived Recombinant Human Serum Albumin Sales by Country (2024-2034)
3.6.3 Asia Pacific Plant-Derived Recombinant Human Serum Albumin Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Plant-Derived Recombinant Human Serum Albumin Market Facts & Figures by Country
3.7.1 Latin America Plant-Derived Recombinant Human Serum Albumin Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Plant-Derived Recombinant Human Serum Albumin Sales by Country (2024-2034)
3.7.3 Latin America Plant-Derived Recombinant Human Serum Albumin Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Plant-Derived Recombinant Human Serum Albumin Market Facts & Figures by Country
3.8.1 Middle East and Africa Plant-Derived Recombinant Human Serum Albumin Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Plant-Derived Recombinant Human Serum Albumin Sales by Country (2024-2034)
3.8.3 Middle East and Africa Plant-Derived Recombinant Human Serum Albumin Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Plant-Derived Recombinant Human Serum Albumin Sales by Type (2024-2034)
4.1.1 Global Plant-Derived Recombinant Human Serum Albumin Sales by Type (2024-2024)
4.1.2 Global Plant-Derived Recombinant Human Serum Albumin Sales by Type (2024-2034)
4.1.3 Global Plant-Derived Recombinant Human Serum Albumin Sales Market Share by Type (2024-2034)
4.2 Global Plant-Derived Recombinant Human Serum Albumin Revenue by Type (2024-2034)
4.2.1 Global Plant-Derived Recombinant Human Serum Albumin Revenue by Type (2024-2024)
4.2.2 Global Plant-Derived Recombinant Human Serum Albumin Revenue by Type (2024-2034)
4.2.3 Global Plant-Derived Recombinant Human Serum Albumin Revenue Market Share by Type (2024-2034)
4.3 Global Plant-Derived Recombinant Human Serum Albumin Price by Type (2024-2034)
5 Segment by Application
5.1 Global Plant-Derived Recombinant Human Serum Albumin Sales by Application (2024-2034)
5.1.1 Global Plant-Derived Recombinant Human Serum Albumin Sales by Application (2024-2024)
5.1.2 Global Plant-Derived Recombinant Human Serum Albumin Sales by Application (2024-2034)
5.1.3 Global Plant-Derived Recombinant Human Serum Albumin Sales Market Share by Application (2024-2034)
5.2 Global Plant-Derived Recombinant Human Serum Albumin Revenue by Application (2024-2034)
5.2.1 Global Plant-Derived Recombinant Human Serum Albumin Revenue by Application (2024-2024)
5.2.2 Global Plant-Derived Recombinant Human Serum Albumin Revenue by Application (2024-2034)
5.2.3 Global Plant-Derived Recombinant Human Serum Albumin Revenue Market Share by Application (2024-2034)
5.3 Global Plant-Derived Recombinant Human Serum Albumin Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Albumedix
6.1.1 Albumedix Corporation Information
6.1.2 Albumedix Description and Business Overview
6.1.3 Albumedix Plant-Derived Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Albumedix Plant-Derived Recombinant Human Serum Albumin Product Portfolio
6.1.5 Albumedix Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Plant-Derived Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Merck Plant-Derived Recombinant Human Serum Albumin Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Ventria (InVitria)
6.3.1 Ventria (InVitria) Corporation Information
6.3.2 Ventria (InVitria) Description and Business Overview
6.3.3 Ventria (InVitria) Plant-Derived Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Ventria (InVitria) Plant-Derived Recombinant Human Serum Albumin Product Portfolio
6.3.5 Ventria (InVitria) Recent Developments/Updates
6.4 Novozymes Biopharma
6.4.1 Novozymes Biopharma Corporation Information
6.4.2 Novozymes Biopharma Description and Business Overview
6.4.3 Novozymes Biopharma Plant-Derived Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Novozymes Biopharma Plant-Derived Recombinant Human Serum Albumin Product Portfolio
6.4.5 Novozymes Biopharma Recent Developments/Updates
6.5 CSL Limited
6.5.1 CSL Limited Corporation Information
6.5.2 CSL Limited Description and Business Overview
6.5.3 CSL Limited Plant-Derived Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2024-2024)
6.5.4 CSL Limited Plant-Derived Recombinant Human Serum Albumin Product Portfolio
6.5.5 CSL Limited Recent Developments/Updates
6.6 LGC Group
6.6.1 LGC Group Corporation Information
6.6.2 LGC Group Description and Business Overview
6.6.3 LGC Group Plant-Derived Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2024-2024)
6.6.4 LGC Group Plant-Derived Recombinant Human Serum Albumin Product Portfolio
6.6.5 LGC Group Recent Developments/Updates
6.7 Bipha Ayurveda (IHI Corporation)
6.6.1 Bipha Ayurveda (IHI Corporation) Corporation Information
6.6.2 Bipha Ayurveda (IHI Corporation) Description and Business Overview
6.6.3 Bipha Ayurveda (IHI Corporation) Plant-Derived Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Bipha Ayurveda (IHI Corporation) Plant-Derived Recombinant Human Serum Albumin Product Portfolio
6.7.5 Bipha Ayurveda (IHI Corporation) Recent Developments/Updates
6.8 Wuhan Healthgen Biotechnology Corp.
6.8.1 Wuhan Healthgen Biotechnology Corp. Corporation Information
6.8.2 Wuhan Healthgen Biotechnology Corp. Description and Business Overview
6.8.3 Wuhan Healthgen Biotechnology Corp. Plant-Derived Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Wuhan Healthgen Biotechnology Corp. Plant-Derived Recombinant Human Serum Albumin Product Portfolio
6.8.5 Wuhan Healthgen Biotechnology Corp. Recent Developments/Updates
6.9 Takeda Pharmaceutical Company Limited
6.9.1 Takeda Pharmaceutical Company Limited Corporation Information
6.9.2 Takeda Pharmaceutical Company Limited Description and Business Overview
6.9.3 Takeda Pharmaceutical Company Limited Plant-Derived Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2024-2024)
6.9.4 Takeda Pharmaceutical Company Limited Plant-Derived Recombinant Human Serum Albumin Product Portfolio
6.9.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
6.10 NCPC
6.10.1 NCPC Corporation Information
6.10.2 NCPC Description and Business Overview
6.10.3 NCPC Plant-Derived Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2024-2024)
6.10.4 NCPC Plant-Derived Recombinant Human Serum Albumin Product Portfolio
6.10.5 NCPC Recent Developments/Updates
6.11 Oryzogen
6.11.1 Oryzogen Corporation Information
6.11.2 Oryzogen Plant-Derived Recombinant Human Serum Albumin Description and Business Overview
6.11.3 Oryzogen Plant-Derived Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2024-2024)
6.11.4 Oryzogen Plant-Derived Recombinant Human Serum Albumin Product Portfolio
6.11.5 Oryzogen Recent Developments/Updates
6.12 HiMedia
6.12.1 HiMedia Corporation Information
6.12.2 HiMedia Plant-Derived Recombinant Human Serum Albumin Description and Business Overview
6.12.3 HiMedia Plant-Derived Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2024-2024)
6.12.4 HiMedia Plant-Derived Recombinant Human Serum Albumin Product Portfolio
6.12.5 HiMedia Recent Developments/Updates
6.13 Grifols
6.13.1 Grifols Corporation Information
6.13.2 Grifols Plant-Derived Recombinant Human Serum Albumin Description and Business Overview
6.13.3 Grifols Plant-Derived Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2024-2024)
6.13.4 Grifols Plant-Derived Recombinant Human Serum Albumin Product Portfolio
6.13.5 Grifols Recent Developments/Updates
6.14 Aspira Chemical
6.14.1 Aspira Chemical Corporation Information
6.14.2 Aspira Chemical Plant-Derived Recombinant Human Serum Albumin Description and Business Overview
6.14.3 Aspira Chemical Plant-Derived Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2024-2024)
6.14.4 Aspira Chemical Plant-Derived Recombinant Human Serum Albumin Product Portfolio
6.14.5 Aspira Chemical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Plant-Derived Recombinant Human Serum Albumin Industry Chain Analysis
7.2 Plant-Derived Recombinant Human Serum Albumin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Plant-Derived Recombinant Human Serum Albumin Production Mode & Process
7.4 Plant-Derived Recombinant Human Serum Albumin Sales and Marketing
7.4.1 Plant-Derived Recombinant Human Serum Albumin Sales Channels
7.4.2 Plant-Derived Recombinant Human Serum Albumin Distributors
7.5 Plant-Derived Recombinant Human Serum Albumin Customers
8 Plant-Derived Recombinant Human Serum Albumin Market Dynamics
8.1 Plant-Derived Recombinant Human Serum Albumin Industry Trends
8.2 Plant-Derived Recombinant Human Serum Albumin Market Drivers
8.3 Plant-Derived Recombinant Human Serum Albumin Market Challenges
8.4 Plant-Derived Recombinant Human Serum Albumin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Plant-Derived Recombinant Human Serum Albumin Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Plant-Derived Recombinant Human Serum Albumin Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Plant-Derived Recombinant Human Serum Albumin Market Competitive Situation by Manufacturers in 2022
Table 4. Global Plant-Derived Recombinant Human Serum Albumin Sales (Units) of Key Manufacturers (2024-2024)
Table 5. Global Plant-Derived Recombinant Human Serum Albumin Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Plant-Derived Recombinant Human Serum Albumin Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Plant-Derived Recombinant Human Serum Albumin Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Plant-Derived Recombinant Human Serum Albumin Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Plant-Derived Recombinant Human Serum Albumin, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Plant-Derived Recombinant Human Serum Albumin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Plant-Derived Recombinant Human Serum Albumin, Product Type & Application
Table 12. Global Key Manufacturers of Plant-Derived Recombinant Human Serum Albumin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Plant-Derived Recombinant Human Serum Albumin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plant-Derived Recombinant Human Serum Albumin as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Plant-Derived Recombinant Human Serum Albumin Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Plant-Derived Recombinant Human Serum Albumin Sales by Region (2024-2024) & (Units)
Table 18. Global Plant-Derived Recombinant Human Serum Albumin Sales Market Share by Region (2024-2024)
Table 19. Global Plant-Derived Recombinant Human Serum Albumin Sales by Region (2024-2034) & (Units)
Table 20. Global Plant-Derived Recombinant Human Serum Albumin Sales Market Share by Region (2024-2034)
Table 21. Global Plant-Derived Recombinant Human Serum Albumin Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Plant-Derived Recombinant Human Serum Albumin Revenue Market Share by Region (2024-2024)
Table 23. Global Plant-Derived Recombinant Human Serum Albumin Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Plant-Derived Recombinant Human Serum Albumin Revenue Market Share by Region (2024-2034)
Table 25. North America Plant-Derived Recombinant Human Serum Albumin Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Plant-Derived Recombinant Human Serum Albumin Sales by Country (2024-2024) & (Units)
Table 27. North America Plant-Derived Recombinant Human Serum Albumin Sales by Country (2024-2034) & (Units)
Table 28. North America Plant-Derived Recombinant Human Serum Albumin Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Plant-Derived Recombinant Human Serum Albumin Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Plant-Derived Recombinant Human Serum Albumin Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Plant-Derived Recombinant Human Serum Albumin Sales by Country (2024-2024) & (Units)
Table 32. Europe Plant-Derived Recombinant Human Serum Albumin Sales by Country (2024-2034) & (Units)
Table 33. Europe Plant-Derived Recombinant Human Serum Albumin Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Plant-Derived Recombinant Human Serum Albumin Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Plant-Derived Recombinant Human Serum Albumin Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Plant-Derived Recombinant Human Serum Albumin Sales by Region (2024-2024) & (Units)
Table 37. Asia Pacific Plant-Derived Recombinant Human Serum Albumin Sales by Region (2024-2034) & (Units)
Table 38. Asia Pacific Plant-Derived Recombinant Human Serum Albumin Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Plant-Derived Recombinant Human Serum Albumin Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Plant-Derived Recombinant Human Serum Albumin Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Plant-Derived Recombinant Human Serum Albumin Sales by Country (2024-2024) & (Units)
Table 42. Latin America Plant-Derived Recombinant Human Serum Albumin Sales by Country (2024-2034) & (Units)
Table 43. Latin America Plant-Derived Recombinant Human Serum Albumin Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Plant-Derived Recombinant Human Serum Albumin Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Plant-Derived Recombinant Human Serum Albumin Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Plant-Derived Recombinant Human Serum Albumin Sales by Country (2024-2024) & (Units)
Table 47. Middle East & Africa Plant-Derived Recombinant Human Serum Albumin Sales by Country (2024-2034) & (Units)
Table 48. Middle East & Africa Plant-Derived Recombinant Human Serum Albumin Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Plant-Derived Recombinant Human Serum Albumin Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Plant-Derived Recombinant Human Serum Albumin Sales (Units) by Type (2024-2024)
Table 51. Global Plant-Derived Recombinant Human Serum Albumin Sales (Units) by Type (2024-2034)
Table 52. Global Plant-Derived Recombinant Human Serum Albumin Sales Market Share by Type (2024-2024)
Table 53. Global Plant-Derived Recombinant Human Serum Albumin Sales Market Share by Type (2024-2034)
Table 54. Global Plant-Derived Recombinant Human Serum Albumin Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Plant-Derived Recombinant Human Serum Albumin Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Plant-Derived Recombinant Human Serum Albumin Revenue Market Share by Type (2024-2024)
Table 57. Global Plant-Derived Recombinant Human Serum Albumin Revenue Market Share by Type (2024-2034)
Table 58. Global Plant-Derived Recombinant Human Serum Albumin Price (US$/Unit) by Type (2024-2024)
Table 59. Global Plant-Derived Recombinant Human Serum Albumin Price (US$/Unit) by Type (2024-2034)
Table 60. Global Plant-Derived Recombinant Human Serum Albumin Sales (Units) by Application (2024-2024)
Table 61. Global Plant-Derived Recombinant Human Serum Albumin Sales (Units) by Application (2024-2034)
Table 62. Global Plant-Derived Recombinant Human Serum Albumin Sales Market Share by Application (2024-2024)
Table 63. Global Plant-Derived Recombinant Human Serum Albumin Sales Market Share by Application (2024-2034)
Table 64. Global Plant-Derived Recombinant Human Serum Albumin Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Plant-Derived Recombinant Human Serum Albumin Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Plant-Derived Recombinant Human Serum Albumin Revenue Market Share by Application (2024-2024)
Table 67. Global Plant-Derived Recombinant Human Serum Albumin Revenue Market Share by Application (2024-2034)
Table 68. Global Plant-Derived Recombinant Human Serum Albumin Price (US$/Unit) by Application (2024-2024)
Table 69. Global Plant-Derived Recombinant Human Serum Albumin Price (US$/Unit) by Application (2024-2034)
Table 70. Albumedix Corporation Information
Table 71. Albumedix Description and Business Overview
Table 72. Albumedix Plant-Derived Recombinant Human Serum Albumin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. Albumedix Plant-Derived Recombinant Human Serum Albumin Product
Table 74. Albumedix Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Plant-Derived Recombinant Human Serum Albumin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. Merck Plant-Derived Recombinant Human Serum Albumin Product
Table 79. Merck Recent Developments/Updates
Table 80. Ventria (InVitria) Corporation Information
Table 81. Ventria (InVitria) Description and Business Overview
Table 82. Ventria (InVitria) Plant-Derived Recombinant Human Serum Albumin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 83. Ventria (InVitria) Plant-Derived Recombinant Human Serum Albumin Product
Table 84. Ventria (InVitria) Recent Developments/Updates
Table 85. Novozymes Biopharma Corporation Information
Table 86. Novozymes Biopharma Description and Business Overview
Table 87. Novozymes Biopharma Plant-Derived Recombinant Human Serum Albumin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 88. Novozymes Biopharma Plant-Derived Recombinant Human Serum Albumin Product
Table 89. Novozymes Biopharma Recent Developments/Updates
Table 90. CSL Limited Corporation Information
Table 91. CSL Limited Description and Business Overview
Table 92. CSL Limited Plant-Derived Recombinant Human Serum Albumin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 93. CSL Limited Plant-Derived Recombinant Human Serum Albumin Product
Table 94. CSL Limited Recent Developments/Updates
Table 95. LGC Group Corporation Information
Table 96. LGC Group Description and Business Overview
Table 97. LGC Group Plant-Derived Recombinant Human Serum Albumin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 98. LGC Group Plant-Derived Recombinant Human Serum Albumin Product
Table 99. LGC Group Recent Developments/Updates
Table 100. Bipha Ayurveda (IHI Corporation) Corporation Information
Table 101. Bipha Ayurveda (IHI Corporation) Description and Business Overview
Table 102. Bipha Ayurveda (IHI Corporation) Plant-Derived Recombinant Human Serum Albumin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 103. Bipha Ayurveda (IHI Corporation) Plant-Derived Recombinant Human Serum Albumin Product
Table 104. Bipha Ayurveda (IHI Corporation) Recent Developments/Updates
Table 105. Wuhan Healthgen Biotechnology Corp. Corporation Information
Table 106. Wuhan Healthgen Biotechnology Corp. Description and Business Overview
Table 107. Wuhan Healthgen Biotechnology Corp. Plant-Derived Recombinant Human Serum Albumin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 108. Wuhan Healthgen Biotechnology Corp. Plant-Derived Recombinant Human Serum Albumin Product
Table 109. Wuhan Healthgen Biotechnology Corp. Recent Developments/Updates
Table 110. Takeda Pharmaceutical Company Limited Corporation Information
Table 111. Takeda Pharmaceutical Company Limited Description and Business Overview
Table 112. Takeda Pharmaceutical Company Limited Plant-Derived Recombinant Human Serum Albumin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. Takeda Pharmaceutical Company Limited Plant-Derived Recombinant Human Serum Albumin Product
Table 114. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 115. NCPC Corporation Information
Table 116. NCPC Description and Business Overview
Table 117. NCPC Plant-Derived Recombinant Human Serum Albumin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. NCPC Plant-Derived Recombinant Human Serum Albumin Product
Table 119. NCPC Recent Developments/Updates
Table 120. Oryzogen Corporation Information
Table 121. Oryzogen Description and Business Overview
Table 122. Oryzogen Plant-Derived Recombinant Human Serum Albumin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 123. Oryzogen Plant-Derived Recombinant Human Serum Albumin Product
Table 124. Oryzogen Recent Developments/Updates
Table 125. HiMedia Corporation Information
Table 126. HiMedia Description and Business Overview
Table 127. HiMedia Plant-Derived Recombinant Human Serum Albumin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 128. HiMedia Plant-Derived Recombinant Human Serum Albumin Product
Table 129. HiMedia Recent Developments/Updates
Table 130. Grifols Corporation Information
Table 131. Grifols Description and Business Overview
Table 132. Grifols Plant-Derived Recombinant Human Serum Albumin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 133. Grifols Plant-Derived Recombinant Human Serum Albumin Product
Table 134. Grifols Recent Developments/Updates
Table 135. Aspira Chemical Corporation Information
Table 136. Aspira Chemical Description and Business Overview
Table 137. Aspira Chemical Plant-Derived Recombinant Human Serum Albumin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 138. Aspira Chemical Plant-Derived Recombinant Human Serum Albumin Product
Table 139. Aspira Chemical Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Plant-Derived Recombinant Human Serum Albumin Distributors List
Table 143. Plant-Derived Recombinant Human Serum Albumin Customers List
Table 144. Plant-Derived Recombinant Human Serum Albumin Market Trends
Table 145. Plant-Derived Recombinant Human Serum Albumin Market Drivers
Table 146. Plant-Derived Recombinant Human Serum Albumin Market Challenges
Table 147. Plant-Derived Recombinant Human Serum Albumin Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Plant-Derived Recombinant Human Serum Albumin
Figure 2. Global Plant-Derived Recombinant Human Serum Albumin Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Plant-Derived Recombinant Human Serum Albumin Market Share by Type in 2022 & 2034
Figure 4. OsrHSA Product Picture
Figure 5. ScrHSA Product Picture
Figure 6. Global Plant-Derived Recombinant Human Serum Albumin Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Plant-Derived Recombinant Human Serum Albumin Market Share by Application in 2022 & 2034
Figure 8. Scientific Research
Figure 9. Pharmaceutical
Figure 10. Others
Figure 11. Global Plant-Derived Recombinant Human Serum Albumin Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 12. Global Plant-Derived Recombinant Human Serum Albumin Market Size (2024-2034) & (US$ Million)
Figure 13. Global Plant-Derived Recombinant Human Serum Albumin Sales (2024-2034) & (Units)
Figure 14. Global Plant-Derived Recombinant Human Serum Albumin Average Price (US$/Unit) & (2024-2034)
Figure 15. Plant-Derived Recombinant Human Serum Albumin Report Years Considered
Figure 16. Plant-Derived Recombinant Human Serum Albumin Sales Share by Manufacturers in 2022
Figure 17. Global Plant-Derived Recombinant Human Serum Albumin Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Plant-Derived Recombinant Human Serum Albumin Players: Market Share by Revenue in 2022
Figure 19. Plant-Derived Recombinant Human Serum Albumin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 20. Global Plant-Derived Recombinant Human Serum Albumin Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 21. North America Plant-Derived Recombinant Human Serum Albumin Sales Market Share by Country (2024-2034)
Figure 22. North America Plant-Derived Recombinant Human Serum Albumin Revenue Market Share by Country (2024-2034)
Figure 23. United States Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 24. Canada Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 25. Europe Plant-Derived Recombinant Human Serum Albumin Sales Market Share by Country (2024-2034)
Figure 26. Europe Plant-Derived Recombinant Human Serum Albumin Revenue Market Share by Country (2024-2034)
Figure 27. Germany Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 28. France Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 29. U.K. Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 30. Italy Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. Russia Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. Asia Pacific Plant-Derived Recombinant Human Serum Albumin Sales Market Share by Region (2024-2034)
Figure 33. Asia Pacific Plant-Derived Recombinant Human Serum Albumin Revenue Market Share by Region (2024-2034)
Figure 34. China Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 35. Japan Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 36. South Korea Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 37. India Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. Australia Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. China Taiwan Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. Southeast Asia Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. Latin America Plant-Derived Recombinant Human Serum Albumin Sales Market Share by Country (2024-2034)
Figure 42. Latin America Plant-Derived Recombinant Human Serum Albumin Revenue Market Share by Country (2024-2034)
Figure 43. Mexico Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Brazil Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. Argentina Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 46. Middle East & Africa Plant-Derived Recombinant Human Serum Albumin Sales Market Share by Country (2024-2034)
Figure 47. Middle East & Africa Plant-Derived Recombinant Human Serum Albumin Revenue Market Share by Country (2024-2034)
Figure 48. Turkey Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 49. Saudi Arabia Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. UAE Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 51. Global Sales Market Share of Plant-Derived Recombinant Human Serum Albumin by Type (2024-2034)
Figure 52. Global Revenue Market Share of Plant-Derived Recombinant Human Serum Albumin by Type (2024-2034)
Figure 53. Global Plant-Derived Recombinant Human Serum Albumin Price (US$/Unit) by Type (2024-2034)
Figure 54. Global Sales Market Share of Plant-Derived Recombinant Human Serum Albumin by Application (2024-2034)
Figure 55. Global Revenue Market Share of Plant-Derived Recombinant Human Serum Albumin by Application (2024-2034)
Figure 56. Global Plant-Derived Recombinant Human Serum Albumin Price (US$/Unit) by Application (2024-2034)
Figure 57. Plant-Derived Recombinant Human Serum Albumin Value Chain
Figure 58. Plant-Derived Recombinant Human Serum Albumin Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed